🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Guangdong Marubi Biotechnology Co., Ltd. (SHA:603983)
China flag China · Delayed Price · Currency is CNY
26.43
-1.44 (-5.17%)
Nov 20, 2026, 3:00 PM CST

SHA:603983 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
1,2841,2502,0321,0771,073806.1
Short-Term Investments
-154.4244.08279.64333.41115.15
Trading Asset Securities
419.51388.66395.7767.98437.78738.09
Cash & Short-Term Investments
1,7041,7932,4722,1241,8441,659
Cash Growth
-17.20%-27.45%16.36%15.19%11.14%-33.37%
Accounts Receivable
37.238.446.4331.573.9362.85
Other Receivables
19.3522.1211.5714.647.437.42
Receivables
56.5560.525846.1481.3670.26
Inventory
208.81233.35219.66171.73151.7138.43
Prepaid Expenses
-9.1812.52--4.9
Other Current Assets
170.56139.34192.31187.75159.99102.88
Total Current Assets
2,1402,2362,9542,5302,2371,976
Property, Plant & Equipment
950.19931.771,082769.91520.59384.14
Long-Term Investments
173.3261.03217.8563.6173.8775.12
Other Intangible Assets
384.97394.15699.16719.58748.63764.56
Long-Term Deferred Tax Assets
148.52110.8391.8559.142.1621.67
Long-Term Deferred Charges
25.9821.231.743.172.589.98
Other Long-Term Assets
740.02658.5615.76308.41469.07530.38
Total Assets
4,5634,6135,0634,4544,0943,762

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
253188.12253.14178.15152.94154.46
Accrued Expenses
24.16209.28167.8156.78156.8104.95
Short-Term Debt
455395790.1100.07100-
Current Portion of Long-Term Debt
---148.12.1-
Current Portion of Leases
0.810.832.364.058.654.79
Current Income Taxes Payable
38.0320.6932.6715.4527.9824.76
Current Unearned Revenue
170.45184.82195.12240.494.53144.57
Other Current Liabilities
166.16200.08155.34167.19125.47143.02
Total Current Liabilities
1,1081,1991,5971,010668.47576.55
Long-Term Debt
----148-
Long-Term Leases
1.411.981.53.2511.6814.68
Long-Term Unearned Revenue
3.914.245.396.165.569.51
Long-Term Deferred Tax Liabilities
23.6914.2512.2615.237.852.45
Other Long-Term Liabilities
--0.360.36--
Total Liabilities
1,1371,2191,6161,035841.56603.19

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
401401401401401.44401.82
Additional Paid-In Capital
761765.28761760.45774.49780.12
Retained Earnings
2,2042,1672,2202,1872,0281,930
Treasury Stock
-----14.47-26.66
Comprehensive Income & Other
-1.81-1.73-1.71-1.58-1.49-1.28
Total Common Equity
3,3643,3313,3803,3473,1883,084
Minority Interest
62.3863.0266.171.4264.5174.36
Shareholders' Equity
3,4263,3943,4473,4193,2533,158
Total Liabilities & Equity
4,5634,6135,0634,4544,0943,762

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
457.22397.81793.97255.48270.4419.47
Net Cash (Debt)
1,2471,3961,6781,8691,5741,640
Net Cash Growth
-15.87%-16.82%-10.22%18.75%-4.03%-31.21%
Net Cash Per Share
3.103.504.174.683.894.10
Filing Date Shares Outstanding
401401401401401.44401.82
Total Common Shares Outstanding
401401401401401.44401.82
Working Capital
1,0321,0371,3581,5201,5691,399
Book Value Per Share
8.398.318.438.357.947.68
Tangible Book Value
2,9792,9372,6812,6282,4392,320
Tangible Book Value Per Share
7.437.326.696.556.085.77
Buildings
-911.4507.12476.51274.43274.43
Machinery
-108.2693.0485.3973.5263.46
Construction In Progress
-22.89603.06309.48253.24118.62